메뉴 건너뛰기




Volumn 86, Issue 5-6, 2014, Pages 308-317

The addition of C-reactive protein to validated staging systems improves their prognostic ability in patients with hepatocellular carcinoma

Author keywords

C reactive protein; Hepatocellular carcinoma; Prognosis; Staging system

Indexed keywords

C REACTIVE PROTEIN;

EID: 84902015226     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000360704     Document Type: Article
Times cited : (15)

References (37)
  • 1
    • 84860287080 scopus 로고    scopus 로고
    • Epidemiology of viral hepatitis and hepatocellular carcinoma
    • El-Serag HB: Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012; 142: 1264.e1-1273.e1
    • (2012) Gastroenterology , vol.142
    • El-Serag, H.B.1
  • 3
    • 0032879468 scopus 로고    scopus 로고
    • Prognosis of hepatocellular carcinoma: The BCLC staging classification
    • Llovet JM, Bru C, Bruix J: Prognosis of hepatocellular carcinoma: The BCLC staging classification. Semin Liver Dis 1999; 19: 329-338
    • (1999) Semin Liver Dis , vol.19 , pp. 329-338
    • Llovet, J.M.1    Bru, C.2    Bruix, J.3
  • 4
    • 0031782818 scopus 로고    scopus 로고
    • A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators
    • A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients: The Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 1998; 28: 751-755
    • (1998) Hepatology , vol.28 , pp. 751-755
  • 5
    • 10644225254 scopus 로고    scopus 로고
    • Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score
    • Kudo M, Chung H, Haji S, Osaki Y, Oka H, Seki T, Kasugai H, Sasaki Y, Matsunaga T: Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP score. Hepatology 2004; 40: 1396-1405
    • (2004) Hepatology , vol.40 , pp. 1396-1405
    • Kudo, M.1    Chung, H.2    Haji, S.3    Osaki, Y.4    Oka, H.5    Seki, T.6    Kasugai, H.7    Sasaki, Y.8    Matsunaga, T.9
  • 7
    • 84858658381 scopus 로고    scopus 로고
    • European organisation for research and treatment of cancer: Easl-eortc clinical practice guidelines: Management of hepatocellular carcinoma
    • European Association for the Study of the Liver
    • European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer: EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943
    • (2012) J Hepatol , vol.56 , pp. 908-943
  • 10
    • 40949127006 scopus 로고    scopus 로고
    • Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response
    • Guglielmi A, Ruzzenente A, Pachera S, Valdegamberi A, Sandri M, D'Onofrio M, Iacono C: Comparison of seven staging systems in cirrhotic patients with hepatocellular carcinoma in a cohort of patients who underwent radiofrequency ablation with complete response. Am J Gastroenterol 2008; 103: 597-604
    • (2008) Am J Gastroenterol , vol.103 , pp. 597-604
    • Guglielmi, A.1    Ruzzenente, A.2    Pachera, S.3    Valdegamberi, A.4    Sandri, M.5    D'Onofrio, M.6    Iacono, C.7
  • 11
    • 84863522066 scopus 로고    scopus 로고
    • Kim do Y, Ahn SH, Park MS, Kim EH, Seong J, Lee do Y, Han KH: Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1,717 treatment- naive patients with hepatocellular carcinoma
    • Kim BK, Kim SU, Park JY, Kim do Y, Ahn SH, Park MS, Kim EH, Seong J, Lee do Y, Han KH: Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: Single centre experience from long-term clinical outcomes of 1,717 treatment- naive patients with hepatocellular carcinoma. Liver Int 2012; 32: 1120-1127
    • (2012) Liver Int , vol.32 , pp. 1120-1127
    • Kim, B.K.1    Kim, S.U.2    Park, J.Y.3
  • 13
    • 84869080379 scopus 로고    scopus 로고
    • Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems
    • Shao YY, Lu LC, Lin ZZ, Hsu C, Shen YC, Hsu CH, Cheng AL: Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems. Br J Cancer 2012; 107: 1672-1677
    • (2012) Br J Cancer , vol.107 , pp. 1672-1677
    • Shao, Y.Y.1    Lu, L.C.2    Lin, Z.Z.3    Hsu, C.4    Shen, Y.C.5    Hsu, C.H.6    Cheng, A.L.7
  • 19
    • 34249322375 scopus 로고    scopus 로고
    • Staging of hepatocellular carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan
    • Minagawa M, Ikai I, Matsuyama Y, Yamaoka Y, Makuuchi M: Staging of hepatocellular carcinoma: Assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Ann Surg 2007; 245: 909-922
    • (2007) Ann Surg , vol.245 , pp. 909-922
    • Minagawa, M.1    Ikai, I.2    Matsuyama, Y.3    Yamaoka, Y.4    Makuuchi, M.5
  • 20
    • 0015370847 scopus 로고
    • Clinical biostatisticsx XVI The process of prognostic stratification
    • Feinsten AR: Clinical biostatisticsx. XVI. The process of prognostic stratification. Clin Pharmacol Ther 1972; 13: 609-624
    • (1972) Clin Pharmacol Ther , vol.13 , pp. 609-624
    • Feinsten, A.R.1
  • 21
    • 0034861620 scopus 로고    scopus 로고
    • Discrimination value of the new western prognostic system (clip score) for hepatocellular carcinoma in 662 japanese patients cancer of the liver italian program
    • Ueno S, Tanabe G, Sako K, Hiwaki T, Hokotate H, Fukukura Y, Baba Y, Imamura Y, Aikou T: Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program. Hepatology 2001; 34: 529-534
    • (2001) Hepatology , vol.34 , pp. 529-534
    • Ueno, S.1    Tanabe, G.2    Sako, K.3    Hiwaki, T.4    Hokotate, H.5    Fukukura, Y.6    Baba, Y.7    Imamura, Y.8    Aikou, T.9
  • 22
    • 75149189004 scopus 로고    scopus 로고
    • Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
    • Roxburgh CS, McMillan DC: Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6: 149-163
    • (2010) Future Oncol , vol.6 , pp. 149-163
    • Roxburgh, C.S.1    McMillan, D.C.2
  • 23
    • 51749126004 scopus 로고    scopus 로고
    • C-reactive protein in liver cancer surgery
    • Stiff GM, Gomez D, Prasad KR: C-reactive protein in liver cancer surgery. Eur J Surg Oncol 2008; 34: 727-729
    • (2008) Eur J Surg Oncol , vol.34 , pp. 727-729
    • Stiff, G.M.1    Gomez, D.2    Prasad, K.R.3
  • 24
    • 34250873779 scopus 로고    scopus 로고
    • A systematic review of the association between circulating concentrations of C reactive protein and cancer
    • Heikkila K, Ebrahim S, Lawlor DA: A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007; 61: 824-833
    • (2007) J Epidemiol Community Health , vol.61 , pp. 824-833
    • Heikkila, K.1    Ebrahim, S.2    Lawlor, D.A.3
  • 26
    • 48649109203 scopus 로고    scopus 로고
    • Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis
    • Sakurai T, He G, Matsuzawa A, Yu GY, Maeda S, Hardiman G, Karin M: Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. Cancer Cell 2008; 14: 156-165
    • (2008) Cancer Cell , vol.14 , pp. 156-165
    • Sakurai, T.1    He, G.2    Matsuzawa, A.3    Yu, G.Y.4    Maeda, S.5    Hardiman, G.6    Karin, M.7
  • 27
    • 73149100826 scopus 로고    scopus 로고
    • Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin- 6 expression
    • Maeda S, Hikiba Y, Sakamoto K, Nakagawa H, Hirata Y, Hayakawa Y, Yanai A, Ogura K, Karin M, Omata M: Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin- 6 expression. Hepatology 2009; 50: 1851-1860
    • (2009) Hepatology , vol.50 , pp. 1851-1860
    • Maeda, S.1    Hikiba, Y.2    Sakamoto, K.3    Nakagawa, H.4    Hirata, Y.5    Hayakawa, Y.6    Yanai, A.7    Ogura, K.8    Karin, M.9    Omata, M.10
  • 28
  • 31
    • 83555163795 scopus 로고    scopus 로고
    • Impact of an inflammation- based prognostic system on patients undergoing surgery for hepatocellular carcinoma: A retrospective study of 398 Japanese patients
    • Ishizuka M, Kubota K, Kita J, Shimoda M, Kato M, Sawada T: Impact of an inflammation- based prognostic system on patients undergoing surgery for hepatocellular carcinoma: A retrospective study of 398 Japanese patients. Am J Surg 2012; 203: 101-106
    • (2012) Am J Surg , vol.203 , pp. 101-106
    • Ishizuka, M.1    Kubota, K.2    Kita, J.3    Shimoda, M.4    Kato, M.5    Sawada, T.6
  • 34
    • 84865865572 scopus 로고    scopus 로고
    • Comparison of the prognostic value of inflammation- based prognostic scores in patients with hepatocellular carcinoma
    • Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Fushiya N, Koike K, Nishino H, Tajiri H: Comparison of the prognostic value of inflammation- based prognostic scores in patients with hepatocellular carcinoma. Br J Cancer 2012; 107: 988-993
    • (2012) Br J Cancer , vol.107 , pp. 988-993
    • Kinoshita, A.1    Onoda, H.2    Imai, N.3    Iwaku, A.4    Oishi, M.5    Fushiya, N.6    Koike, K.7    Nishino, H.8    Tajiri, H.9
  • 35
    • 84872153048 scopus 로고    scopus 로고
    • Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system
    • Hsu CY, Lee YH, Hsia CY, Huang YH, Su CW, Lin HC, Lee RC, Chiou YY, Lee FY, Huo TI: Performance status in patients with hepatocellular carcinoma: Determinants, prognostic impact, and ability to improve the Barcelona Clinic Liver Cancer system. Hepatology 2013; 57: 112-119
    • (2013) Hepatology , vol.57 , pp. 112-119
    • Hsu, C.Y.1    Lee, Y.H.2    Hsia, C.Y.3    Huang, Y.H.4    Su, C.W.5    Lin, H.C.6    Lee, R.C.7    Chiou, Y.Y.8    Lee, F.Y.9    Huo, T.I.10
  • 36
    • 84874112331 scopus 로고    scopus 로고
    • The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma
    • Diouf M, Filleron T, Barbare JC, Fin L, Picard C, Bouche O, Dahan L, Paoletti X, Bonnetain F: The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. J Hepatol 2013; 58: 509-521
    • (2013) J Hepatol , vol.58 , pp. 509-521
    • Diouf, M.1    Filleron, T.2    Barbare, J.C.3    Fin, L.4    Picard, C.5    Bouche, O.6    Dahan, L.7    Paoletti, X.8    Bonnetain, F.9
  • 37
    • 84876986843 scopus 로고    scopus 로고
    • The systemic inflammationbased Glasgow Prognostic Score: A decade of experience in patients with cancer
    • McMillan DC: The systemic inflammationbased Glasgow Prognostic Score: A decade of experience in patients with cancer. Cancer Treat Rev 2013; 39: 534-540.
    • (2013) Cancer Treat Rev , vol.39 , pp. 534-540
    • McMillan, D.C.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.